SLC2A3 encodes the GLUT3. Because of excessively high glucose consumption of tumor cells, aberrant GLUT family expression, including GLUT3, is known to associate with poor prognosis in various cancers, including brain tumors. Here, SLC2A3 is linked to neoplasm.